Correvio Pharma Corp

(NASDAQ:CORV)

Latest On Correvio Pharma Corp (CORV):

Date/Time Type Description Signal Details
2020-09-19 08:41 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:32 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 20:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 00:37 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:40 ESTFinancialsCompany financials have been released.Neutral
2020-07-10 08:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 08:26 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 16:36 ESTAnalyst RatingThe Analyst Target Price has increased from $1.08 to $1.75.Buy
2020-05-31 16:58 ESTFinancialsCompany financials have been released.Neutral
2020-05-05 00:42 ESTNewsCorrevio postpones Q1 results due to COVID-19N/A
2020-05-03 08:32 ESTFinancialsCompany financials have been released.Neutral
2020-04-11 08:43 ESTNewsCorrevio up 41% on Aggrastat deal in AsiaN/A
2020-04-11 08:38 ESTNewsAdvanz Pharma to buy Correvio Pharma for $76MN/A
2020-04-11 08:19 ESTNewsCorrevio Pharma EPS misses by $0.01, misses on revenueN/A
2020-04-07 12:28 ESTFinancialsCompany financials have been released.Neutral
2020-04-07 00:37 ESTFinancialsCompany financials have been released.Neutral
2020-04-07 00:37 ESTEarnings EstimateAn EPS average of -$0.18 is estimated for the 2021 year.Sell
2020-04-07 00:37 ESTEarnings EstimateAn EPS average of -$0.09 is estimated for the quarter ending on June 30, 2020.Sell
2020-04-06 04:22 ESTFinancialsCompany financials have been released.Neutral
2020-04-02 04:23 ESTFinancialsCompany financials have been released.Neutral
2020-03-18 00:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $3.12 to $1.08.Neutral
2020-02-28 23:29 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 03:30 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 03:30 ESTEarningsEarnings have been released on May 16, 2017, with -$0.20 earnings per share.Sell
2020-02-21 23:24 ESTFinancialsCompany financials have been released.Neutral
2020-02-14 23:22 ESTFinancialsCompany financials have been released.Neutral
2020-02-06 23:26 ESTFinancialsCompany financials have been released.Neutral
2020-01-29 23:26 ESTFinancialsCompany financials have been released.Neutral
2020-01-28 03:31 ESTEarningsEarnings have been released on November 14, 2019, with -$0.23 earnings per share.Sell
2020-01-28 03:31 ESTEarningsEarnings have been released on May 8, 2019, with -$0.23 earnings per share.Sell
2020-01-28 03:31 ESTEarningsEarnings have been released on March 13, 2019, with -$0.18 earnings per share.Buy
2020-01-28 03:31 ESTEarningsEarnings have been released on November 15, 2017, with -$0.20 earnings per share.Sell
2020-01-27 23:24 ESTFinancialsCompany financials have been released.Neutral
2020-01-15 23:25 ESTFinancialsCompany financials have been released.Neutral
2019-12-24 09:23 ESTNewsCORV -1.5% on FDA complete response letterN/A
2019-12-21 23:16 ESTFinancialsCompany financials have been released.Neutral
2019-12-21 08:30 ESTNewsStocks To Watch: Amazon To Star On Boxing DayN/A
2019-12-17 03:15 ESTAnalyst RatingThe Analyst Target Price has decreased from $4.74 to $3.12.Neutral
2019-12-16 23:24 ESTFinancialsCompany financials have been released.Neutral
2019-12-16 11:11 ESTNewsGoldman likes Amgen and UnitedHealth Group in premarket analyst actionN/A
2019-12-11 12:52 ESTNewsGME, AEO among premarket losersN/A
2019-12-11 12:51 ESTNewsMicrobot Medical leads healthcare gainers; Correvio Pharma tops the losersN/A
2019-12-11 12:51 ESTNewsGME, MDGL, MBOT and OLLI among midday moversN/A
2019-12-11 09:05 ESTNewsWells cuts view on Cigna in premarket analyst actionN/A
2019-12-11 09:05 ESTNewsCorrevio to explore strategic alternatives after Ad Com snub of Brinavess for AFN/A
2019-12-10 18:19 ESTNewsFDA advisory committee thumbs down on Correvio's Brinavess for AFN/A
2019-12-10 08:45 ESTNewsCorrevio shares halted for Ad Com review of Brinavess for AFN/A
2019-12-10 03:16 ESTAnalyst RatingThe Analyst Target Price has decreased from $5.84 to $4.74.Neutral
2019-12-09 09:22 ESTNewsBLUE, PCG among premarket gainersN/A
2019-12-06 14:00 ESTNewsTRNX, YEXT, BIG and CGIX among midday moversN/A

About Correvio Pharma Corp (CORV):

Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. Its products comprise Aggrastat (tirofiban hydrochloride), (an intravenous anti-platelet drug for patients with acute coronary syndrome; and Brinavess (vernakalant IV), a novel, atrial-preferential antiarrhythmic agent for the rapid conversion of recent onset atrial fibrillation to sinus rhythm. The company also offers Trevyent, a development stage drug/device combination product for pulmonary arterial hypertension; Xydalba, a treatment for acute bacterial skin and skin structure infections; and Zevtera/Mabelio, a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria. Correvio Pharma Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.

CORV Quotes by TradingView

See Advanced Chart

General

  • Name Correvio Pharma Corp
  • Symbol CORV
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers—Specialty & Generic
  • Full Time Employees 133
  • Last Split Factor1:5
  • Last Split Date2013-04-12
  • Fiscal Year EndDecember
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.correvio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 0.57
  • Price/Book (Most Recent Quarter) 10.46
  • Enterprise Value Revenue 1.89
View More

Financials

  • Most Recent Quarter 2019-12-31
  • Current Year EPS Estimate -$0.31
  • Next Year EPS Estimate -$0.06
  • Profit Margin -108%
  • Operating Margin -84%
  • Return on Assets -29%
  • Return on Equity -1158%
  • Revenue 32.63 million
  • Earnings Per Share -$0.88
  • Revenue Per Share $0.74
  • Gross Profit 22.81 million
  • Quarterly Earnings Growth 26.6%
View More

Highlights

  • Market Capitalization 27.79 million
  • EBITDA -19143000
  • Analyst Target Price $1.75
  • Book Value Per Share $0.03
View More

Share Statistics

  • Shares Outstanding 66.19 million
  • Shares Float 61.32 million
  • % Held by Insiders 724%
  • % Held by Institutions 6.99%
  • Shares Short 2.31 million
  • Shares Short Prior Month 3.76 million
  • Short Ratio 0.78
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 0.22
  • 52 Week High $2.51
  • 52 Week Low $0.25
  • 50 Day Moving Average 0.41
  • 200 Day Moving Average 0.4
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

Correvio Pharma Corp (CORV) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Correvio Pharma Corp (CORV) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2019-12-312020-03-30$N/A-$0.07-$0.1241.67%
2019-09-302019-11-14$6.67 million-$0.23-$0.17-35.29%
2019-06-302019-08-14$7.39 million-$0.26-$0.23-13.04%
2019-03-312019-05-08$7.25 million-$0.23-$0.20-15%
2018-12-312019-03-13$8.95 million-$0.18-$0.2115%
2018-09-302018-11-07$7.01 million-$0.20-$0.20-1.6%
2018-06-302018-08-15$6.18 million$0.16-$0.15203.47%
2018-03-312018-05-16$6.54 million-$0.24-$0.08-205.13%
2017-12-312018-03-14$7.03 million-$0.24-$0.18-34.56%
2017-09-302017-11-15$6.02 million-$0.20-$0.18-10.67%
2017-06-302017-08-09$5.75 million-$0.26
2017-03-312017-05-16$5.2 million-$0.20-$0.17-16.82%
2016-12-312017-03-08$7.02 million-$0.18
2016-09-302016-11-07$5.24 million-$0.19
2016-06-302016-08-10$5.91 million-$0.37
2016-03-312016-05-13$7.09 million-$0.06
2015-12-312016-03-10$4.72 million-$0.41
2015-09-302015-11-13$4.96 million-$0.31
2015-06-302015-08-05$5.74 million-$0.43
2015-03-312015-05-13$5.5 million-$0.23
2014-12-312015-03-12$6.98 million-$0.40
2014-09-302014-11-07$7.81 million-$0.26
2014-06-302014-08-11$7.67 million-$0.26
2014-03-312014-05-13$7.59 million-$0.20
2013-12-312014-03-27$3.87 million-$0.53
2013-09-302013-11-06$477000-$0.29
2013-06-302013-08-02$107000-$0.22
2013-03-312013-05-13$60000$1.47
2012-12-312013-03-15$84000$0.63
2012-09-302012-11-14$63000-$1.10
2012-06-302012-08-08$209000-$0.46
2012-03-312012-05-11$433000-$0.57
2011-12-312012-03-27$401000-$0.48
2011-09-302011-11-04$274000-$0.59
2011-06-302011-08-08$443000-$0.63
2011-03-312011-05-17$387000-$0.58
2010-12-312011-03-11$374000-$0.60
2010-09-302010-11-12$30.22 million$1.84
2010-06-302010-08-11$12.42 million$0.36
2010-03-312010-05-12$23.05 million$1.23
2009-12-312010-03-10$23.53 million$0.97
2009-09-302009-11-09$19.71 million-$0.03
2009-06-302009-08-11$7.37 million-$0.10
2009-03-312009-05-16$217287.87-$0.76
2008-12-312009-03-30$336949.38-$0.50
2008-09-302008-11-17$503522.78-$0.88
2008-06-302008-08-14$197825.87-$1.40
2008-03-312008-05-14$444401.13-$1.73
2007-12-312008-03-26$1.11 million-$2.05
2007-09-302007-11-14$969238.53-$2.37
2007-06-302007-08-09$1.04 million-$1.05
2007-03-312007-05-11$1.48 million-$0.99
2006-12-312007-03-28$11.22 million-$0.09
2006-09-302006-11-13$2.15 million-$1.00
2006-06-302006-08-14$1.91 million-$1.24
2006-03-312006-05-15$2.61 million-$0.67
2005-09-302005-11-14$4.01 million-$2.40
2005-06-302005-08-11$3.11 million-$0.61
2005-03-312005-05-16$3.81 million-$0.74
2004-12-312005-03-01$9.68 million$0.20
2004-09-302004-11-15$3.57 million-$1.45
2004-06-302004-08-12$3.95 million-$0.92
2004-03-312004-05-16$3.81 million-$0.48

Correvio Pharma Corp (CORV) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Correvio Pharma Corp (CORV) Chart:

Correvio Pharma Corp (CORV) News:

Below you will find a list of latest news for Correvio Pharma Corp (CORV) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Correvio Pharma Corp (CORV) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Correvio Pharma Corp (CORV) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-0915-12GSecurities registration termination [Section 12(g)]https://www.sec.gov/Archives/edgar/data/1036141/000134100420000241/0001341004-20-000241-index.htm
2019-01-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000089383819000005/0000893838-19-000005-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000093583619000105/0000935836-19-000105-index.htm
2018-07-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000108514618001615/0001085146-18-001615-index.htm
2019-04-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000108514619001081/0001085146-19-001081-index.htm
2019-09-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000108514619002410/0001085146-19-002410-index.htm
2020-01-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000108514620000013/0001085146-20-000013-index.htm
2019-02-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000109544919000008/0001095449-19-000008-index.htm
2019-02-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000109544919000010/0001095449-19-000010-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000109544920000019/0001095449-20-000019-index.htm
2019-12-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000110465919075850/0001104659-19-075850-index.htm
2019-12-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000110465919075852/0001104659-19-075852-index.htm
2019-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000117625619000107/0001176256-19-000107-index.htm
2019-05-036-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000117625619000135/0001176256-19-000135-index.htm
2019-05-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000117625619000176/0001176256-19-000176-index.htm
2020-03-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000117625620000081/0001176256-20-000081-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000119312519039677/0001193125-19-039677-index.htm
2020-02-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000119312520045560/0001193125-20-045560-index.htm
2020-04-3020-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1036141/000119312520127179/0001193125-20-127179-index.htm
2020-04-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000121465920003430/0001214659-20-003430-index.htm
2020-05-26SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000121465920005020/0001214659-20-005020-index.htm
2018-05-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1036141/000127956918001135/0001279569-18-001135-index.htm
2018-06-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001260/0001279569-18-001260-index.htm
2018-06-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001294/0001279569-18-001294-index.htm
2018-06-25F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1036141/000127956918001344/0001279569-18-001344-index.htm
2018-06-25F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1036141/000127956918001348/0001279569-18-001348-index.htm
2018-07-05F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1036141/000127956918001414/0001279569-18-001414-index.htm
2018-07-10SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001440/0001279569-18-001440-index.htm
2018-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001444/0001279569-18-001444-index.htm
2018-07-1220-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001462/0001279569-18-001462-index.htm
2018-07-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001516/0001279569-18-001516-index.htm
2018-08-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001568/0001279569-18-001568-index.htm
2018-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001620/0001279569-18-001620-index.htm
2018-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001710/0001279569-18-001710-index.htm
2018-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001713/0001279569-18-001713-index.htm
2018-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001714/0001279569-18-001714-index.htm
2018-08-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001735/0001279569-18-001735-index.htm
2018-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001768/0001279569-18-001768-index.htm
2018-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001790/0001279569-18-001790-index.htm
2018-09-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001800/0001279569-18-001800-index.htm
2018-09-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918001897/0001279569-18-001897-index.htm
2018-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918002082/0001279569-18-002082-index.htm
2018-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918002119/0001279569-18-002119-index.htm
2018-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918002130/0001279569-18-002130-index.htm
2018-11-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918002211/0001279569-18-002211-index.htm
2018-11-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918002213/0001279569-18-002213-index.htm
2018-11-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956918002332/0001279569-18-002332-index.htm
2019-01-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000006/0001279569-19-000006-index.htm
2019-01-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000056/0001279569-19-000056-index.htm
2019-01-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000104/0001279569-19-000104-index.htm
2019-02-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000230/0001279569-19-000230-index.htm
2019-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000372/0001279569-19-000372-index.htm
2019-03-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000499/0001279569-19-000499-index.htm
2019-03-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000516/0001279569-19-000516-index.htm
2019-03-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000535/0001279569-19-000535-index.htm
2019-03-1340-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000563/0001279569-19-000563-index.htm
2019-03-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000565/0001279569-19-000565-index.htm
2019-03-14SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000574/0001279569-19-000574-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000583/0001279569-19-000583-index.htm
2019-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000622/0001279569-19-000622-index.htm
2019-03-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000644/0001279569-19-000644-index.htm
2019-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000803/0001279569-19-000803-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000810/0001279569-19-000810-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919000811/0001279569-19-000811-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001011/0001279569-19-001011-index.htm
2019-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001090/0001279569-19-001090-index.htm
2019-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001091/0001279569-19-001091-index.htm
2019-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001397/0001279569-19-001397-index.htm
2019-06-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001422/0001279569-19-001422-index.htm
2019-07-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001582/0001279569-19-001582-index.htm
2019-08-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001634/0001279569-19-001634-index.htm
2019-08-02SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001640/0001279569-19-001640-index.htm
2019-08-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001654/0001279569-19-001654-index.htm
2019-08-02SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001660/0001279569-19-001660-index.htm
2019-08-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001662/0001279569-19-001662-index.htm
2019-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001680/0001279569-19-001680-index.htm
2019-08-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001709/0001279569-19-001709-index.htm
2019-08-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001738/0001279569-19-001738-index.htm
2019-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001744/0001279569-19-001744-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001773/0001279569-19-001773-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001776/0001279569-19-001776-index.htm
2019-09-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001856/0001279569-19-001856-index.htm
2019-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001866/0001279569-19-001866-index.htm
2019-09-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001922/0001279569-19-001922-index.htm
2019-09-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919001993/0001279569-19-001993-index.htm
2019-11-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002248/0001279569-19-002248-index.htm
2019-11-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002274/0001279569-19-002274-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002330/0001279569-19-002330-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002331/0001279569-19-002331-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002360/0001279569-19-002360-index.htm
2019-11-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002395/0001279569-19-002395-index.htm
2019-12-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002474/0001279569-19-002474-index.htm
2019-12-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002475/0001279569-19-002475-index.htm
2019-12-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002480/0001279569-19-002480-index.htm
2019-12-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956919002519/0001279569-19-002519-index.htm
2020-01-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000110/0001279569-20-000110-index.htm
2020-03-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000235/0001279569-20-000235-index.htm
2020-03-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000274/0001279569-20-000274-index.htm
2020-03-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000314/0001279569-20-000314-index.htm
2020-03-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000369/0001279569-20-000369-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000425/0001279569-20-000425-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000431/0001279569-20-000431-index.htm
2020-04-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000496/0001279569-20-000496-index.htm
2020-04-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000564/0001279569-20-000564-index.htm
2020-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000649/0001279569-20-000649-index.htm
2020-05-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000659/0001279569-20-000659-index.htm
2020-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000680/0001279569-20-000680-index.htm
2020-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000800/0001279569-20-000800-index.htm
2020-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000127956920000824/0001279569-20-000824-index.htm
2020-05-27F-10POSPost-effective amendment to a F-10EF registrationhttps://www.sec.gov/Archives/edgar/data/1036141/000134100420000223/0001341004-20-000223-index.htm
2020-05-27S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1036141/000134100420000224/0001341004-20-000224-index.htm
2020-05-27S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1036141/000134100420000225/0001341004-20-000225-index.htm
2020-05-27POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1036141/000134100420000226/0001341004-20-000226-index.htm
2020-05-27POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1036141/000134100420000227/0001341004-20-000227-index.htm
2020-05-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1036141/000134100420000228/0001341004-20-000228-index.htm
2020-06-0915-12GSecurities registration termination [Section 12(g)]https://www.sec.gov/Archives/edgar/data/1036141/000134100420000241/0001341004-20-000241-index.htm
2020-05-2725-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1036141/000135445720000204/0001354457-20-000204-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000142157819000011/0001421578-19-000011-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1036141/000142157820000007/0001421578-20-000007-index.htm
2018-07-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1036141/999999999518001723/9999999995-18-001723-index.htm
2020-05-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1036141/999999999520001258/9999999995-20-001258-index.htm
2020-05-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1036141/999999999520001264/9999999995-20-001264-index.htm
2018-08-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1036141/999999999718007353/9999999997-18-007353-index.htm